Baystate Wealth Management’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1M Buy
18,075
+14,924
+474% +$769K 0.07% 95
2023
Q3
$157K Sell
3,151
-62
-2% -$3.22K 0.01% 214
2023
Q2
$167K Sell
3,213
-271
-8% -$13.7K 0.01% 205
2023
Q1
$172K Buy
3,484
+839
+32% +$41.4K 0.02% 192
2022
Q4
$126K Buy
2,645
+46
+2% +$2.19K 0.01% 229
2022
Q3
$115K Hold
2,599
0.01% 220
2022
Q2
$124K Buy
2,599
+26
+1% +$1.38K 0.01% 216
2022
Q1
$150K Sell
2,573
-99
-4% -$5.87K 0.01% 200
2021
Q4
$162K Buy
2,672
+65
+2% +$3.95K 0.01% 196
2021
Q3
$158K Buy
2,607
+2,035
+356% +$125K 0.02% 169
2021
Q2
$36K Buy
572
+115
+25% +$7.06K ﹤0.01% 311
2021
Q1
$27K Sell
457
-174
-28% -$10.3K ﹤0.01% 325
2020
Q4
$36K Buy
+631
New +$32.3K ﹤0.01% 284

Other funds holding EMXC

Baystate Wealth Management's EMXC Position: Q4 2023 in Review

Baystate Wealth Management increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 474% in Q4 2023, buying an estimated $769K and bringing the position to 18,075 shares worth $1M. The position accounts for 0.07% of the portfolio, ranked #95.

Baystate Wealth Management first reported a position in EMXC in Q4 2020 and has held it in 13 quarters since. 656 funds tracked by Wall St. Rank hold EMXC as of Q4 2023.

  • Baystate Wealth Management held 18,075 shares of iShares MSCI Emerging Markets ex China ETF worth $1M as of Q4 2023.
  • Baystate Wealth Management bought 14,924 iShares MSCI Emerging Markets ex China ETF shares in Q4 2023, an estimated $769K.
  • iShares MSCI Emerging Markets ex China ETF made up 0.07% of Baystate Wealth Management's portfolio in Q4 2023, its #95 holding.
  • Baystate Wealth Management first reported a position in iShares MSCI Emerging Markets ex China ETF in Q4 2020 and has held it in 13 quarters since.
  • 656 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.